Experts around the world are reviewing the current composition of anticovid vaccines, although it is still too early to determine whether it will be necessary to develop a new one against the omicron variant, an expert from the World Health Organization (WHO) highlighted today.
“We have the experience of the flu vaccine and we have created a working group in coordination with the pharmaceutical sector to determine if a specific vaccine against the new variant is necessary, but it is still too early,” the epidemiologist highlighted at a press conference. from WHO Abdi Mahamud.
The expert added that omicron’s high transmissibility will cause it to become the dominant variant in many parts of the world, which represents a danger for those countries that still have large population groups unvaccinated.
Before thinking about booster vaccines (some countries already consider a fourth dose) "access to vaccines needs to be guaranteed in overcrowded countries with lower-middle income levels", he claimed.
Mutations of the virus "They occur in unvaccinated people, therefore tackling this problem is an imperative need to stop this disease, ”Mahamud stressed.
.